Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Trading Update

10 Jul 2014 07:00

RNS Number : 8753L
Swallowfield PLC
10 July 2014
 

Swallowfield plc

("Swallowfield" or the "Company")

 

Trading Update

 

Swallowfield plc, a market leader in the development, formulation, and supply of personal care and beauty products; whose customers include many of the world's leading brands, today provides an update on trading for the year ending 30th June 2014 prior to entering its close period.

 

The board is pleased to announce that following a year of stabilisation and re-focus we anticipate a return to full year profitability in line with market expectations.

 

The Group has made good progress across its 4 strategic pillars (Product Category Focus, Cost Base Optimisation, New Product Development, Emerging New Category) in line with our new strategy as outlined in the interim results.

 

Particularly pleasing has been the positive impact achieved on contribution margin as a result of executing our Product Category Focus and continuing to improve our cost base. This performance has offset a slight softness in sales revenues versus expectations. This softness has been due to the challenging retail market which has resulted in a slow-down in volumes from some of our brand customers.

 

Despite this, overall revenues in the 53 weeks are expected to show growth of 3% (1% on a 52 week basis), with the prior year comparative including £2m of sales lost due to previously advised changes in sourcing strategy from a small number of major customers. Underlying sales growth excluding these sales is just over 7% (5% on a 52 week basis).

 

Our balance sheet also continues to strengthen with tight control of inventories and cash leading to an improvement in our net debt position to £5.1m, versus prior year £5.7m.

 

Outlook

 

We expect the challenging retail market conditions currently being experienced in the UK and Europe to continue in the short and medium term.

 

However, the Board remains confident that the new strategy outlined earlier this year will gain further momentum, improve profitability and continue to build shareholder value. In addition, the new financial year will benefit from improved run rate profitability, further efficiencies, tighter control of working capital and new product developments already progressed in the 2013/14 financial year.

 

The Company expects to announce its results for the year-ended 30th June 2014 on 18th September 2014.

 

 

 

 

 

For further information please contact:

Swallowfield plc

Chris How Chief Executive Officer 01823 662 241

Mark Warren Group Finance Director 01823 662 241

 

Jonny Franklin-Adams/

Jen Boorer N+1 Singer 0207 496 3000

Alan Bulmer Investor Focus International 07831 654744

Chris Lawrance JBP Public Relations 0117 907 3400

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRLMTTMBAMBBI
Date   Source Headline
13th Apr 20225:19 pmRNSForm 8.3 - Brand Architekts Group PLC
13th Apr 20224:03 pmRNSForm 8.3 - Offeree - InnovaDerma PLC
13th Apr 20223:22 pmGNWForm 8.3 - Brand Architekts Group plc
13th Apr 20229:26 amRNSForm 8.3 - Brand Architekts Group Plc
13th Apr 20228:48 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
12th Apr 20223:21 pmRNSForm 8.3 - Brand Architekts Group plc - Replace
12th Apr 20222:04 pmRNSForm 8.5 (EPT/RI)
12th Apr 20229:34 amRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:18 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:17 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:14 pmRNSForm 8 (OPD) InnovaDerma PLC
11th Apr 20226:10 pmRNSForm 8 (OPD) - Brand Architekts plc
11th Apr 20224:04 pmRNSForm 8.3 - Brand Architekts Group PLC
11th Apr 20229:06 amRNSForm 8.5 (EPT/RI)
8th Apr 20225:15 pmRNSForm 8.3 - Brand Architekts Group PLC
8th Apr 202210:31 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
7th Apr 20222:40 pmRNSForm 8.4 - Roger McDowell
7th Apr 20222:40 pmRNSDirector/PDMR Shareholding
7th Apr 20229:53 amRNSForm 8.5 (EPT/RI)
6th Apr 20221:10 pmRNSForm 8.4 - Roger McDowell
6th Apr 20221:00 pmRNSDirector/PDMR Shareholding
6th Apr 202211:00 amRNSForm 8.3 - Brand Architekts Group PLC
6th Apr 202210:56 amRNSForm 8.5 (EPT/RI)
5th Apr 202211:45 amRNSForm 8.5 (EPT/RI)
4th Apr 202211:18 amRNSForm 8.5 (EPT/RI)
1st Apr 20221:40 pmRNSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
1st Apr 202211:53 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
31st Mar 20222:54 pmRNSForm 8.3 - Brand Architekts Group Plc
31st Mar 20221:26 pmGNWForm 8.3 - Octopus Investments - Brand Architekts Group plc
31st Mar 20229:52 amBUSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
31st Mar 20227:01 amRNSRecommended Merger with InnovaDerma Plc
31st Mar 20227:00 amRNSHalf-year Report
1st Mar 20227:00 amRNSBoard Appointment
14th Feb 202210:07 amRNSHolding(s) in Company
6th Dec 20214:01 pmRNSHolding(s) in Company
6th Dec 20213:56 pmRNSHolding(s) in Company
29th Nov 20213:54 pmRNSResult of AGM
4th Nov 20213:25 pmRNSAnnual Report and Accounts & Notice of AGM
12th Oct 202112:40 pmRNSGrant of Options
6th Oct 20213:51 pmRNSHolding(s) in Company
5th Oct 202111:23 amRNSHolding(s) in Company
4th Oct 20212:31 pmRNSHolding(s) in Company
30th Sep 202110:23 amRNSLaunch of marketplace: The Unexpekted Store
28th Sep 20212:56 pmRNSDirector/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results
16th Sep 20217:00 amRNSNotice of Investor Presentation
20th Jul 20217:00 amRNSTrading Update
2nd Jul 202110:57 amRNSHolding(s) in Company
29th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.